Submit Manuscript

Journal of Medical Sciences

Year: 2006 | Volume: 6 | Issue: 4 | Page No.: 626-630
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend

Total views 453

Search

Authors

Nagwa Abd EL-Ghaffar

Nehal Hamdy EL-Said

Keywords

Research Article

Hypoadiponectinaemia in Egyptian Patients with Type II Diabetes Mellitus with Vascular Complications

Nagwa Abd EL-Ghaffar and Nehal Hamdy EL-Said
Adiponectin, a collagen-like plasma protein produced and secreted exclusively by adipose tissue, has been shown to have compelling anti-atherogenic, anti-inflammatory and insulin-sensitizing properties. Adiponectin has been linked to insulin resistance in obesity and diabetes. The aim of the study is to measure serum adiponectin concentration in type II obese diabetic patients with various micro and macrovascular complications, as adiponectin seems to be an important modulator for metabolic and vascular diseases. The study was carried out on 60 obese patients with type II diabetes (30 patients with macrovascular complications and 30 patients with various microvascular complications). The control group consisted of 20 healthy subjects of matched age and sex. For all subjects participated in the study, Body Mass Index (BMI), fasting (FBG) and postprandial (PPBG) blood glucose, creatinine, sodium, potassium, lipid profile and adiponectin were measured. We found a highly significant decrease in serum adiponectin levels in diabetic patients compared with control group. There was a significant negative correlation between adiponectin levels and BMI, FBG, PPBG, creatinine, sodium, potassium, triglyceride, total cholesterol and LDL-C, with significant positive correlation between adiponectin serum levels and duration of diabetes and HDL-C in diabetic patients. These results support the hypothesis that low circulating levels of adiponectin are an important determinant of risk of cardiovascular disease and that increased adiponectin levels might be associated with better glycemic control, better lipid profile and reduced inflammation in diabetic subjects. Thus, therapeutic approaches aimed at increasing concentrations or adiponectin tissue sensitivity and action could represent a novel treatment strategy for insulin resistance in type II diabetes and might have therapeutic implications as an anti-obesity drug or as anti-atherogenic plasma protein.
PDF Fulltext XML References Citation

Related Articles

Tetranucleotide Repeat Polymorphism in the 3' UTR of the Human Leptin Gene and Risk of Type 2 Diabetes Mellitus in a South Indian Population
Insulin Treatment-Induced Daily Changes to Plasma Adiponectin and TNF-α Level and Lipid Metabolism Parameters in Dogs Suffering from Type 1 Diabetes Mellitus
Effect of Momordica charantia Fruit Extract on Normal and Alloxan-Diabetic Rats
Insulin Resistance and Interleukin-1β During Normal Pregnancy
Alternation of Physical Indexes and Plasma Biochemical Makers in Overweight Dogs Induced by High-Fat Diet Feeding

Leave a Comment

Your email address will not be published. Required fields are marked *